These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37231038)

  • 1. Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism.
    Mulcrone PL; Lam AK; Frabutt D; Zhang J; Chrzanowski M; Herzog RW; Xiao W
    Sci Rep; 2023 May; 13(1):8436. PubMed ID: 37231038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.
    Giles AR; Govindasamy L; Somanathan S; Wilson JM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
    Michelfelder S; Varadi K; Raupp C; Hunger A; Körbelin J; Pahrmann C; Schrepfer S; Müller OJ; Kleinschmidt JA; Trepel M
    PLoS One; 2011; 6(8):e23101. PubMed ID: 21850255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
    Yang L; Li J; Xiao X
    Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.
    Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.
    Lam AK; Frabutt D; Li L; Xiao W
    Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.
    Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
    Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
    Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants.
    Benskey MJ; Kuhn NC; Galligan JJ; Garcia J; Boye SE; Hauswirth WW; Mueller C; Boye SL; Manfredsson FP
    Mol Ther; 2015 Mar; 23(3):488-500. PubMed ID: 25592336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.
    Emmanuel SN; Smith JK; Hsi J; Tseng YS; Kaplan M; Mietzsch M; Chipman P; Asokan A; McKenna R; Agbandje-McKenna M
    J Virol; 2022 Feb; 96(3):e0125121. PubMed ID: 34757842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
    Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice.
    Jin Q; Qiao C; Li J; Li J; Xiao X
    Gene Ther; 2020 May; 27(5):237-244. PubMed ID: 31819202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
    Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
    Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.
    Rode L; Bär C; Groß S; Rossi A; Meumann N; Viereck J; Abbas N; Xiao K; Riedel I; Gietz A; Zimmer K; Odenthal M; Büning H; Thum T
    Mol Ther; 2022 Dec; 30(12):3601-3618. PubMed ID: 35810332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the adeno-associated virus capsid in gene transfer.
    Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO
    Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic multi-trait AAV capsid engineering for efficient gene delivery.
    Eid FE; Chen AT; Chan KY; Huang Q; Zheng Q; Tobey IG; Pacouret S; Brauer PP; Keyes C; Powell M; Johnston J; Zhao B; Lage K; Tarantal AF; Chan YA; Deverman BE
    Nat Commun; 2024 Aug; 15(1):6602. PubMed ID: 39097583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.
    Li W; Asokan A; Wu Z; Van Dyke T; DiPrimio N; Johnson JS; Govindaswamy L; Agbandje-McKenna M; Leichtle S; Redmond DE; McCown TJ; Petermann KB; Sharpless NE; Samulski RJ
    Mol Ther; 2008 Jul; 16(7):1252-60. PubMed ID: 18500254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.